Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Prosensa and GSK add to muscular dystrophy alliance

June 23, 2010 Research and Development GlaxoSmithKline, Prosensa, muscular dystrophy

GSK has extended its research alliance with biotech company Prosensa in the field of muscular dystrophy. Netherlands-based Prosensa focuses on …
News
George Osborne

Mixed reaction for Osborne’s first Budget

June 23, 2010 Research and Development, Sales and Marketing biotech, pharma, tax, tax relief

George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …
News

PRA bolsters late phase services

June 23, 2010 Research and Development CRO, PRA, appointment, research and development

Contract research organisation PRA International has appointed Hani Zaki senior VP of its Late Phase Services business. Late Phase Services …
Appointment

Sanofi signs microRNA therapy deal

June 23, 2010 Research and Development RNA, Regulus, Sanofi-Aventis

Sanofi-Aventis has entered into a global strategic alliance with US-based therapeutics firm Regulus to develop and commercialise microRNA therapeutics. Regulus …
News

Medical Affairs at the Centre of Life Sciences Innovation

June 22, 2010 Research and Development Kinapse, Medical Affairs, Real World Development, consulting, outsourcinf

In today’s challenging business environment, many innovative life sciences companies are raising questions about the return on investment of internal …
Feature
Thought Leadership

Europe must move on from ‘simplistic’ pricing

June 22, 2010 Research and Development Europe, hta, pricing, pricing & Reimbursement

GSK chief executive Andrew Witty has called on European governments to scrap outdated pricing systems and embrace newer methods, in …
News
Andrew Witty

Let’s avoid further stand-offs, says Witty

June 22, 2010 Research and Development, Sales and Marketing EFPIA, Greece, industry, pricing

Pharma will need to find new ways of working with European governments in order to avoid further crises as witnessed …
News

Dr Geoffrey Nichol joins Ikaria

June 22, 2010 Research and Development Ikaria, appointment, research and development

US biotherapeutics company Ikaria has appointed Dr Geoffrey Nichol chief medical officer, with responsibility for its late-stage drug development activies. …
Appointment

Working Life: Jo Ferdinando

June 22, 2010 Manufacturing and Production, Research and Development Shire, Working Life, careers

How did you find your way into your most current role? After completing a BSc in Microbiology and Virology at …
Feature
Blog footer

Digital Pharma: Online trial safety reporting

June 21, 2010 Research and Development FDA, MHRA, digital research, drug safety

From September all serious adverse events that occur during clinical trials in the UK will have to be reported electronically …
News

Tasigna more effective than Glivec, says Novartis

June 21, 2010 Research and Development, Sales and Marketing Glivec, Novartis, Tasigna, leukaemia

Novartis has gained US approval for Tasigna to be used as a front line treatment for chronic myeloid leukaemia. The …
News
NHS Football Fitness

Digital Pharma: Byte-sized roundup

June 18, 2010 Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media

This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …
News

Contract research news in brief

June 18, 2010 Research and Development CRO, ClinStar, Covance, ICON, Parexel, Phlexglobal, Quintiles, chiltern, contract research

Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …
News

Bayer signs cancer stem cell research deal

June 18, 2010 Research and Development Bayer Schering Pharma, Cancer, OncoMed, Stem cells

Bayer Schering Pharma has teamed up with a US oncology specialist to develop novel antibodies, protein therapeutics and small molecules …
News

MedImmune Ventures appoints Ron Laufer

June 18, 2010 Research and Development AstraZeneca, MedImmune, appointment, research and development

Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …
Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026